ArabMedicare.com: The Web Portal for Healthcare Professionals


   Medical News Center

  Home Page
Channels
 
Medical News Center
  Conference News
   
   
   
   
Rankings/Surveys
 

Top 25 Hospitals
Arab World

   
 



 



 

 

 

Saturday, 15 October 2016 | ArabMedicare.com | Staff Reporter

 
 


Women's Healthcare Forum addresses reproductive health and family planning issues in Arab countries
 


 
(Dubai) - In conjunction with a growing national and international trend to promote women's and reproductive health, Bayer Pharmaceuticals recently organized the ‘Women's Healthcare Forum’ to highlight the most pertinent issues affecting the health and safety of women as well as the latest developments in the diagnosis, treatment and prevention of diseases associated with complications in pregnancy and childbirth. The event was held from October 13 to 14, 2016 in Dubai.

The forum was held in line with Bayer’s ‘Women's Health Day’ initiative which is part of the pharmaceutical company's corporate social responsibility commitment to raise public awareness on key health issues facing women and children.

Dr. Mona Al Kuwari, an obstetrics and gynecology specialist, led the assembly and initiated an extensive discussion on a number of reproductive health diseases related to endometriosis, including the guidelines for diagnosis and corresponding treatment. Dr Al Kuwari also discussed challenges in proper diagnosis and the role of ultrasound in determining the disease. The forum addressed the issue of hormonal contraception and reviewed the advantages and disadvantages of combined oral contraceptive 24/4 (COCs regimen 24/4) as well. The discussion further touched on the use of levonorgestrel intrauterine injection technology (levonorgestrel intrauterine system- LNG IUS) in clinical practice, as well social and behavioral methods for effectively communicating the technology with various segments of patients. The forum also included a small workshop on ways to apply LNG-IUS.

Hany Sabry, Gulf Country Manager at Bayer Pharmaceuticals, noted that Bayer’s ‘Women's Healthcare Forum’ was organized to provide an interactive platform concerning the latest advancements in women’s reproductive health and how these developments can help improve their health.  Sabry added: "Our ‘Women's Healthcare Forum’ initiative is in line with our endeavors to help ensure long life and good health for all."

During the two-day event, the forum presented a host of distinguished experts and doctors in the field to discuss and share the best practices and methods for diagnosing and treating gynecological diseases, especially the migration of the inner lining of the uterus. Delegates attending were from the UAE, Egypt, Lebanon, Saudi Arabia and Jordan.

 

PRINT THIS ARTICLE

 
 

Women’s Health and Reproductive Care
 
 
 

 

Home  | Search | About Us  | Education  | Business  | Health Centers | Clinical Resources  | Bookstore  | LinksJob Bank | Medical News |Conference News & Analysis | Buying Guide | Events | Products/Services Showcase | Advertise With Us | Contact Us


Copyright © 1999-2016  ArabMedicare.com.  All rights reserved.